ELAN
Price
$11.96
Change
-$0.32 (-2.61%)
Updated
May 9 closing price
Capitalization
7.87B
92 days until earnings call
HCM
Price
$14.21
Change
-$0.33 (-2.27%)
Updated
May 9 closing price
Capitalization
2.88B
17 days until earnings call
Ad is loading...

ELAN vs HCM

Header iconELAN vs HCM Comparison
Open Charts ELAN vs HCMBanner chart's image
Elanco Animal Health
Price$11.96
Change-$0.32 (-2.61%)
Volume$8.52M
Capitalization7.87B
HUTCHMED (China)
Price$14.21
Change-$0.33 (-2.27%)
Volume$41.59K
Capitalization2.88B
ELAN vs HCM Comparison Chart
Loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELAN vs. HCM commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Hold and HCM is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (ELAN: $11.96 vs. HCM: $14.21)
Brand notoriety: ELAN: Notable vs. HCM: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ELAN: 154% vs. HCM: 41%
Market capitalization -- ELAN: $7.87B vs. HCM: $2.88B
ELAN [@Pharmaceuticals: Other] is valued at $7.87B. HCM’s [@Pharmaceuticals: Other] market capitalization is $2.88B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 0 FA rating(s) are green whileHCM’s FA Score has 2 green FA rating(s).

  • ELAN’s FA Score: 0 green, 5 red.
  • HCM’s FA Score: 2 green, 3 red.
According to our system of comparison, HCM is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 5 TA indicator(s) are bullish while HCM’s TA Score has 4 bullish TA indicator(s).

  • ELAN’s TA Score: 5 bullish, 5 bearish.
  • HCM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ELAN is a better buy in the short-term than HCM.

Price Growth

ELAN (@Pharmaceuticals: Other) experienced а +22.67% price change this week, while HCM (@Pharmaceuticals: Other) price change was -5.27% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.06%. For the same industry, the average monthly price growth was +12.42%, and the average quarterly price growth was +15.65%.

Reported Earning Dates

ELAN is expected to report earnings on Aug 11, 2025.

HCM is expected to report earnings on Aug 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.06% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($7.87B) has a higher market cap than HCM($2.88B). ELAN YTD gains are higher at: -1.239 vs. HCM (-1.388). HCM has higher annual earnings (EBITDA): 67.3M vs. ELAN (-224M). HCM has more cash in the bank: 886M vs. ELAN (352M). HCM has less debt than ELAN: HCM (86.1M) vs ELAN (5.77B). ELAN has higher revenues than HCM: ELAN (4.42B) vs HCM (838M).
ELANHCMELAN / HCM
Capitalization7.87B2.88B273%
EBITDA-224M67.3M-333%
Gain YTD-1.239-1.38889%
P/E RatioN/A27.95-
Revenue4.42B838M527%
Total Cash352M886M40%
Total Debt5.77B86.1M6,706%
FUNDAMENTALS RATINGS
ELAN vs HCM: Fundamental Ratings
ELAN
HCM
OUTLOOK RATING
1..100
3216
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8133
PRICE GROWTH RATING
1..100
4756
P/E GROWTH RATING
1..100
967
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HCM's Valuation (90) in the Pharmaceuticals Major industry is in the same range as ELAN (91) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew similarly to ELAN’s over the last 12 months.

HCM's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew similarly to ELAN’s over the last 12 months.

HCM's SMR Rating (33) in the Pharmaceuticals Major industry is somewhat better than the same rating for ELAN (81) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew somewhat faster than ELAN’s over the last 12 months.

ELAN's Price Growth Rating (47) in the Agricultural Commodities Or Milling industry is in the same range as HCM (56) in the Pharmaceuticals Major industry. This means that ELAN’s stock grew similarly to HCM’s over the last 12 months.

HCM's P/E Growth Rating (7) in the Pharmaceuticals Major industry is significantly better than the same rating for ELAN (96) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew significantly faster than ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANHCM
RSI
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
64%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
65%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 7 days ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
74%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
68%
Bullish Trend 4 days ago
76%
Aroon
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SCHH21.220.16
+0.76%
Schwab US REIT ETF™
CMU3.40N/A
N/A
MFS High Yield Municipal Trust
UYG86.94-0.09
-0.11%
ProShares Ultra Financials
EIS82.51-0.37
-0.45%
iShares MSCI Israel ETF
FTXH24.52-0.45
-1.80%
First Trust Nasdaq Pharmaceuticals ETF